APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dog Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Dog Vaccines Market Analysis and Forecast 2026-2032

22 December 2025198 pages

Choose your research edition.

Industry ResearchDog Vaccines Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Dog Vaccines Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Dog Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dog Vaccines Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Dog Vaccines Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Dog Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Dog Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Dog Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Dog Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Dog Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Dog Vaccines include Zoetis (Pfizer), Merck Animal Health, Eli Lilly, Bayer Healthcare, Virbac, Vetoquinol S.A, Merial (Sanofi), Heska Co. and Ceva, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Dog Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Dog Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Dog Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dog Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Dog Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Dog Vaccines sales, projected growth trends, production technology, application and end-user industry.

Dog Vaccines Segment by Company

Zoetis (Pfizer)

Merck Animal Health

Eli Lilly

Bayer Healthcare

Virbac

Vetoquinol S.A

Merial (Sanofi)

Heska Co.

Ceva

Boehringer Ingelheim

Dog Vaccines Segment by Type

Recombinant Vaccines

Subunit Vaccines

Inactivated Vaccines

Toxoid Vaccines

Attenuated Live Vaccines

Conjugate Vaccines

DNA Vaccines

Dog Vaccines Segment by Application

Below 6 Months

Above Months

Dog Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dog Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dog Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dog Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Dog Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Dog Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dog Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Dog Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Recombinant Vaccines Major Manufacturers Table 3. Subunit Vaccines Major Manufacturers Table 4. Inactivated Vaccines Major Manufacturers Table 5. Toxoid Vaccines Major Manufacturers Table 6. Attenuated Live Vaccines Major Manufacturers Table 7. Conjugate Vaccines Major Manufacturers Table 8. DNA Vaccines Major Manufacturers Table 9. Global Dog Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 10. Below 6 Months Major Manufacturers Table 11. Above Months Major Manufacturers Table 12. Dog Vaccines Industry Trends Table 13. Dog Vaccines Industry Drivers Table 14. Dog Vaccines Industry Opportunities and Challenges Table 15. Dog Vaccines Industry Restraints Table 16. Global Dog Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Dog Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Dog Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Dog Vaccines Revenue Market Share by Region (2021-2026) Table 20. Global Dog Vaccines Revenue Market Share by Region (2027-2032) Table 21. Global Dog Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 22. Global Dog Vaccines Sales by Region (2021-2026) & (k units) Table 23. Global Dog Vaccines Sales by Region (2027-2032) & (k units) Table 24. Global Dog Vaccines Sales Market Share by Region (2021-2026) Table 25. Global Dog Vaccines Sales Market Share by Region (2027-2032) Table 26. Global Dog Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Dog Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Dog Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Dog Vaccines Sales Market Share by Manufacturers (2021-2026) Table 30. Global Dog Vaccines Sales Price (US$/unit) of Manufacturers (2021-2026) Table 31. Global Dog Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Dog Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Dog Vaccines Manufacturers, Product Type & Application Table 34. Global Dog Vaccines Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Dog Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Dog Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Dog Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Dog Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Dog Vaccines Revenue Market Share by Type (2021-2026) Table 41. Global Dog Vaccines Revenue Market Share by Type (2027-2032) Table 42. Global Dog Vaccines Sales by Type 2021 VS 2025 VS 2032 (k units) Table 43. Global Dog Vaccines Sales by Type (2021-2026) & (k units) Table 44. Global Dog Vaccines Sales by Type (2027-2032) & (k units) Table 45. Global Dog Vaccines Sales Market Share by Type (2021-2026) Table 46. Global Dog Vaccines Sales Market Share by Type (2027-2032) Table 47. Global Dog Vaccines Price by Type (2021-2026) & (US$/unit) Table 48. Global Dog Vaccines Price by Type (2027-2032) & (US$/unit) Table 49. Global Dog Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Dog Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Dog Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Dog Vaccines Revenue Market Share by Application (2021-2026) Table 53. Global Dog Vaccines Revenue Market Share by Application (2027-2032) Table 54. Global Dog Vaccines Sales by Application 2021 VS 2025 VS 2032 (k units) Table 55. Global Dog Vaccines Sales by Application (2021-2026) & (k units) Table 56. Global Dog Vaccines Sales by Application (2027-2032) & (k units) Table 57. Global Dog Vaccines Sales Market Share by Application (2021-2026) Table 58. Global Dog Vaccines Sales Market Share by Application (2027-2032) Table 59. Global Dog Vaccines Price by Application (2021-2026) & (US$/unit) Table 60. Global Dog Vaccines Price by Application (2027-2032) & (US$/unit) Table 61. Zoetis (Pfizer) Company Information Table 62. Zoetis (Pfizer) Business Overview Table 63. Zoetis (Pfizer) Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Zoetis (Pfizer) Dog Vaccines Product Portfolio Table 65. Zoetis (Pfizer) Recent Development Table 66. Merck Animal Health Company Information Table 67. Merck Animal Health Business Overview Table 68. Merck Animal Health Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Merck Animal Health Dog Vaccines Product Portfolio Table 70. Merck Animal Health Recent Development Table 71. Eli Lilly Company Information Table 72. Eli Lilly Business Overview Table 73. Eli Lilly Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Eli Lilly Dog Vaccines Product Portfolio Table 75. Eli Lilly Recent Development Table 76. Bayer Healthcare Company Information Table 77. Bayer Healthcare Business Overview Table 78. Bayer Healthcare Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Bayer Healthcare Dog Vaccines Product Portfolio Table 80. Bayer Healthcare Recent Development Table 81. Virbac Company Information Table 82. Virbac Business Overview Table 83. Virbac Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Virbac Dog Vaccines Product Portfolio Table 85. Virbac Recent Development Table 86. Vetoquinol S.A Company Information Table 87. Vetoquinol S.A Business Overview Table 88. Vetoquinol S.A Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Vetoquinol S.A Dog Vaccines Product Portfolio Table 90. Vetoquinol S.A Recent Development Table 91. Merial (Sanofi) Company Information Table 92. Merial (Sanofi) Business Overview Table 93. Merial (Sanofi) Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Merial (Sanofi) Dog Vaccines Product Portfolio Table 95. Merial (Sanofi) Recent Development Table 96. Heska Co. Company Information Table 97. Heska Co. Business Overview Table 98. Heska Co. Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Heska Co. Dog Vaccines Product Portfolio Table 100. Heska Co. Recent Development Table 101. Ceva Company Information Table 102. Ceva Business Overview Table 103. Ceva Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Ceva Dog Vaccines Product Portfolio Table 105. Ceva Recent Development Table 106. Boehringer Ingelheim Company Information Table 107. Boehringer Ingelheim Business Overview Table 108. Boehringer Ingelheim Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Boehringer Ingelheim Dog Vaccines Product Portfolio Table 110. Boehringer Ingelheim Recent Development Table 111. North America Dog Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 112. North America Dog Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 113. North America Dog Vaccines Sales by Type (2021-2026) & (k units) Table 114. North America Dog Vaccines Sales by Type (2027-2032) & (k units) Table 115. North America Dog Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 116. North America Dog Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 117. North America Dog Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 118. North America Dog Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 119. North America Dog Vaccines Sales by Application (2021-2026) & (k units) Table 120. North America Dog Vaccines Sales by Application (2027-2032) & (k units) Table 121. North America Dog Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 122. North America Dog Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 123. North America Dog Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. North America Dog Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 125. North America Dog Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 126. North America Dog Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 127. North America Dog Vaccines Sales by Country (2021-2026) & (k units) Table 128. North America Dog Vaccines Sales by Country (2027-2032) & (k units) Table 129. North America Dog Vaccines Sales Price by Country (2021-2026) & (US$/unit) Table 130. North America Dog Vaccines Sales Price by Country (2027-2032) & (US$/unit) Table 131. United States Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 132. Canada Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 133. Mexico Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 134. Europe Dog Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 135. Europe Dog Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 136. Europe Dog Vaccines Sales by Type (2021-2026) & (k units) Table 137. Europe Dog Vaccines Sales by Type (2027-2032) & (k units) Table 138. Europe Dog Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 139. Europe Dog Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 140. Europe Dog Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 141. Europe Dog Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 142. Europe Dog Vaccines Sales by Application (2021-2026) & (k units) Table 143. Europe Dog Vaccines Sales by Application (2027-2032) & (k units) Table 144. Europe Dog Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 145. Europe Dog Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 146. Europe Dog Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Europe Dog Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 148. Europe Dog Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 149. Europe Dog Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 150. Europe Dog Vaccines Sales by Country (2021-2026) & (k units) Table 151. Europe Dog Vaccines Sales by Country (2027-2032) & (k units) Table 152. Europe Dog Vaccines Sales Price by Country (2021-2026) & (US$/unit) Table 153. Europe Dog Vaccines Sales Price by Country (2027-2032) & (US$/unit) Table 154. Germany Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 155. France Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 156. U.K. Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 157. Italy Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 158. Russia Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 159. Spain Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 160. Netherlands Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 161. Switzerland Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 162. Sweden Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 163. Poland Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 164. China Dog Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 165. China Dog Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 166. China Dog Vaccines Sales by Type (2021-2026) & (k units) Table 167. China Dog Vaccines Sales by Type (2027-2032) & (k units) Table 168. China Dog Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 169. China Dog Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 170. China Dog Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 171. China Dog Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 172. China Dog Vaccines Sales by Application (2021-2026) & (k units) Table 173. China Dog Vaccines Sales by Application (2027-2032) & (k units) Table 174. China Dog Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 175. China Dog Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 176. Asia Dog Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 177. Asia Dog Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 178. Asia Dog Vaccines Sales by Type (2021-2026) & (k units) Table 179. Asia Dog Vaccines Sales by Type (2027-2032) & (k units) Table 180. Asia Dog Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 181. Asia Dog Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 182. Asia Dog Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 183. Asia Dog Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 184. Asia Dog Vaccines Sales by Application (2021-2026) & (k units) Table 185. Asia Dog Vaccines Sales by Application (2027-2032) & (k units) Table 186. Asia Dog Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 187. Asia Dog Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 188. Asia Dog Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 189. Asia Dog Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 190. Asia Dog Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 191. Asia Dog Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 192. Asia Dog Vaccines Sales by Country (2021-2026) & (k units) Table 193. Asia Dog Vaccines Sales by Country (2027-2032) & (k units) Table 194. Asia Dog Vaccines Sales Price by Country (2021-2026) & (US$/unit) Table 195. Asia Dog Vaccines Sales Price by Country (2027-2032) & (US$/unit) Table 196. Japan Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 197. South Korea Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 198. India Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 199. Australia Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 200. Taiwan Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 201. Southeast Asia Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 202. SAMEA Dog Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 203. SAMEA Dog Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 204. SAMEA Dog Vaccines Sales by Type (2021-2026) & (k units) Table 205. SAMEA Dog Vaccines Sales by Type (2027-2032) & (k units) Table 206. SAMEA Dog Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 207. SAMEA Dog Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 208. SAMEA Dog Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 209. SAMEA Dog Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 210. SAMEA Dog Vaccines Sales by Application (2021-2026) & (k units) Table 211. SAMEA Dog Vaccines Sales by Application (2027-2032) & (k units) Table 212. SAMEA Dog Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 213. SAMEA Dog Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 214. SAMEA Dog Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 215. SAMEA Dog Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 216. SAMEA Dog Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 217. SAMEA Dog Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 218. SAMEA Dog Vaccines Sales by Country (2021-2026) & (k units) Table 219. SAMEA Dog Vaccines Sales by Country (2027-2032) & (k units) Table 220. SAMEA Dog Vaccines Sales Price by Country (2021-2026) & (US$/unit) Table 221. SAMEA Dog Vaccines Sales Price by Country (2027-2032) & (US$/unit) Table 222. Brazil Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 223. Argentina Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 224. Chile Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 225. Colombia Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 226. Peru Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 227. Saudi Arabia Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 228. Israel Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 229. UAE Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 230. Turkey Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 231. Iran Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 232. Egypt Dog Vaccines Revenue (2021-2032) & (US$ Million) Table 233. Key Raw Materials Table 234. Raw Materials Key Suppliers Table 235. Dog Vaccines Distributors List Table 236. Dog Vaccines Customers List Table 237. Research Programs/Design for This Report Table 238. Authors List of This Report Table 239. Secondary Sources Table 240. Primary Sources List of Figures Figure 1. Dog Vaccines Image Figure 2. Global Dog Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dog Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Recombinant Vaccines Image Figure 5. Subunit Vaccines Image Figure 6. Inactivated Vaccines Image Figure 7. Toxoid Vaccines Image Figure 8. Attenuated Live Vaccines Image Figure 9. Conjugate Vaccines Image Figure 10. DNA Vaccines Image Figure 11. Global Dog Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Dog Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 13. Below 6 Months Image Figure 14. Above Months Image Figure 15. Global Dog Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Dog Vaccines Revenue (2021-2032) & (US$ Million) Figure 17. Global Dog Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Dog Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Dog Vaccines Revenue Market Share by Region (2021-2032) Figure 20. Global Dog Vaccines Sales (2021-2032) & (k units) Figure 21. Global Dog Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 22. Global Dog Vaccines Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Dog Vaccines Sales YoY (2021-2032) & (k units) Figure 24. Europe Dog Vaccines Sales YoY (2021-2032) & (k units) Figure 25. China Dog Vaccines Sales YoY (2021-2032) & (k units) Figure 26. Asia (Excluding China) Dog Vaccines Sales YoY (2021-2032) & (k units) Figure 27. South America, Middle East and Africa Dog Vaccines Sales YoY (2021-2032) & (k units) Figure 28. Global Dog Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Dog Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Dog Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Dog Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Dog Vaccines Revenue Market Share by Type (2021-2032) Figure 34. Global Dog Vaccines Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 35. Global Dog Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Dog Vaccines Sales Market Share by Type (2021-2032) Figure 37. Global Dog Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Dog Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Dog Vaccines Revenue Market Share by Application (2021-2032) Figure 40. Global Dog Vaccines Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 41. Global Dog Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Dog Vaccines Sales Market Share by Application (2021-2032) Figure 43. North America Dog Vaccines Revenue Share by Type (2021-2032) Figure 44. North America Dog Vaccines Sales Share by Type (2021-2032) Figure 45. North America Dog Vaccines Revenue Share by Application (2021-2032) Figure 46. North America Dog Vaccines Sales Share by Application (2021-2032) Figure 47. North America Dog Vaccines Revenue Share by Country (2021-2032) Figure 48. North America Dog Vaccines Sales Share by Country (2021-2032) Figure 49. Europe Dog Vaccines Revenue Share by Type (2021-2032) Figure 50. Europe Dog Vaccines Sales Share by Type (2021-2032) Figure 51. Europe Dog Vaccines Revenue Share by Application (2021-2032) Figure 52. Europe Dog Vaccines Sales Share by Application (2021-2032) Figure 53. Europe Dog Vaccines Revenue Share by Country (2021-2032) Figure 54. Europe Dog Vaccines Sales Share by Country (2021-2032) Figure 55. China Dog Vaccines Revenue Share by Type (2021-2032) Figure 56. China Dog Vaccines Sales Share by Type (2021-2032) Figure 57. China Dog Vaccines Revenue Share by Application (2021-2032) Figure 58. China Dog Vaccines Sales Share by Application (2021-2032) Figure 59. Asia Dog Vaccines Revenue Share by Type (2021-2032) Figure 60. Asia Dog Vaccines Sales Share by Type (2021-2032) Figure 61. Asia Dog Vaccines Revenue Share by Application (2021-2032) Figure 62. Asia Dog Vaccines Sales Share by Application (2021-2032) Figure 63. Asia Dog Vaccines Revenue Share by Country (2021-2032) Figure 64. Asia Dog Vaccines Sales Share by Country (2021-2032) Figure 65. SAMEA Dog Vaccines Revenue Share by Type (2021-2032) Figure 66. SAMEA Dog Vaccines Sales Share by Type (2021-2032) Figure 67. SAMEA Dog Vaccines Revenue Share by Application (2021-2032) Figure 68. SAMEA Dog Vaccines Sales Share by Application (2021-2032) Figure 69. SAMEA Dog Vaccines Revenue Share by Country (2021-2032) Figure 70. SAMEA Dog Vaccines Sales Share by Country (2021-2032) Figure 71. Dog Vaccines Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Dog Vaccines Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant Vaccines
  • Subunit Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Attenuated Live Vaccines
  • Conjugate Vaccines
  • DNA Vaccines
Applications
  • Below 6 Months
  • Above Months
Companies covered
  • Zoetis (Pfizer)
  • Merck Animal Health
  • Eli Lilly
  • Bayer Healthcare
  • Virbac
  • Vetoquinol S.A
  • Merial (Sanofi)
  • Heska Co.
  • Ceva
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Dog Vaccines Market by Type
  3. 1.2.1 Global Dog Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Recombinant Vaccines
  5. 1.2.3 Subunit Vaccines
  6. 1.2.4 Inactivated Vaccines
  7. 1.2.5 Toxoid Vaccines
  8. 1.2.6 Attenuated Live Vaccines
  9. 1.2.7 Conjugate Vaccines
  10. 1.2.8 DNA Vaccines
  11. 1.3 Dog Vaccines Market by Application
  12. 1.3.1 Global Dog Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  13. 1.3.2 Below 6 Months
  14. 1.3.3 Above Months
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Dog Vaccines Market Dynamics
  1. 2.1 Dog Vaccines Industry Trends
  2. 2.2 Dog Vaccines Industry Drivers
  3. 2.3 Dog Vaccines Industry Opportunities and Challenges
  4. 2.4 Dog Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Dog Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Dog Vaccines Revenue by Region
  3. 3.2.1 Global Dog Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Dog Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global Dog Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global Dog Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Dog Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Dog Vaccines Sales by Region
  9. 3.4.1 Global Dog Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Dog Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global Dog Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global Dog Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Dog Vaccines Revenue by Manufacturers
  2. 4.1.1 Global Dog Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Dog Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Dog Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Dog Vaccines Sales by Manufacturers
  6. 4.2.1 Global Dog Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Dog Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Dog Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Dog Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Dog Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Dog Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Dog Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global Dog Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Dog Vaccines Market CR5 and HHI
  16. 4.8.2 2025 Dog Vaccines Tier 1, Tier 2, and Tier 3
5 Dog Vaccines Market by Type
  1. 5.1 Global Dog Vaccines Revenue by Type
  2. 5.1.1 Global Dog Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Dog Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Dog Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Dog Vaccines Sales by Type
  6. 5.2.1 Global Dog Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dog Vaccines Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Dog Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Dog Vaccines Price by Type
6 Dog Vaccines Market by Application
  1. 6.1 Global Dog Vaccines Revenue by Application
  2. 6.1.1 Global Dog Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Dog Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Dog Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Dog Vaccines Sales by Application
  6. 6.2.1 Global Dog Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Dog Vaccines Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Dog Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Dog Vaccines Price by Application
7 Company Profiles
  1. 7.1 Zoetis (Pfizer)
  2. 7.1.1 Zoetis (Pfizer) Company Information
  3. 7.1.2 Zoetis (Pfizer) Business Overview
  4. 7.1.3 Zoetis (Pfizer) Dog Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Zoetis (Pfizer) Dog Vaccines Product Portfolio
  6. 7.1.5 Zoetis (Pfizer) Recent Developments
  7. 7.2 Merck Animal Health
  8. 7.2.1 Merck Animal Health Company Information
  9. 7.2.2 Merck Animal Health Business Overview
  10. 7.2.3 Merck Animal Health Dog Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Animal Health Dog Vaccines Product Portfolio
  12. 7.2.5 Merck Animal Health Recent Developments
  13. 7.3 Eli Lilly
  14. 7.3.1 Eli Lilly Company Information
  15. 7.3.2 Eli Lilly Business Overview
  16. 7.3.3 Eli Lilly Dog Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Eli Lilly Dog Vaccines Product Portfolio
  18. 7.3.5 Eli Lilly Recent Developments
  19. 7.4 Bayer Healthcare
  20. 7.4.1 Bayer Healthcare Company Information
  21. 7.4.2 Bayer Healthcare Business Overview
  22. 7.4.3 Bayer Healthcare Dog Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Bayer Healthcare Dog Vaccines Product Portfolio
  24. 7.4.5 Bayer Healthcare Recent Developments
  25. 7.5 Virbac
  26. 7.5.1 Virbac Company Information
  27. 7.5.2 Virbac Business Overview
  28. 7.5.3 Virbac Dog Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Virbac Dog Vaccines Product Portfolio
  30. 7.5.5 Virbac Recent Developments
  31. 7.6 Vetoquinol S.A
  32. 7.6.1 Vetoquinol S.A Company Information
  33. 7.6.2 Vetoquinol S.A Business Overview
  34. 7.6.3 Vetoquinol S.A Dog Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Vetoquinol S.A Dog Vaccines Product Portfolio
  36. 7.6.5 Vetoquinol S.A Recent Developments
  37. 7.7 Merial (Sanofi)
  38. 7.7.1 Merial (Sanofi) Company Information
  39. 7.7.2 Merial (Sanofi) Business Overview
  40. 7.7.3 Merial (Sanofi) Dog Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Merial (Sanofi) Dog Vaccines Product Portfolio
  42. 7.7.5 Merial (Sanofi) Recent Developments
  43. 7.8 Heska Co.
  44. 7.8.1 Heska Co. Company Information
  45. 7.8.2 Heska Co. Business Overview
  46. 7.8.3 Heska Co. Dog Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Heska Co. Dog Vaccines Product Portfolio
  48. 7.8.5 Heska Co. Recent Developments
  49. 7.9 Ceva
  50. 7.9.1 Ceva Company Information
  51. 7.9.2 Ceva Business Overview
  52. 7.9.3 Ceva Dog Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Ceva Dog Vaccines Product Portfolio
  54. 7.9.5 Ceva Recent Developments
  55. 7.10 Boehringer Ingelheim
  56. 7.10.1 Boehringer Ingelheim Company Information
  57. 7.10.2 Boehringer Ingelheim Business Overview
  58. 7.10.3 Boehringer Ingelheim Dog Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Boehringer Ingelheim Dog Vaccines Product Portfolio
  60. 7.10.5 Boehringer Ingelheim Recent Developments
8 North America
  1. 8.1 North America Dog Vaccines Market Size by Type
  2. 8.1.1 North America Dog Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America Dog Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America Dog Vaccines Price by Type (2021-2032)
  5. 8.2 North America Dog Vaccines Market Size by Application
  6. 8.2.1 North America Dog Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America Dog Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America Dog Vaccines Price by Application (2021-2032)
  9. 8.3 North America Dog Vaccines Market Size by Country
  10. 8.3.1 North America Dog Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Dog Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Dog Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Dog Vaccines Market Size by Type
  2. 9.1.1 Europe Dog Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe Dog Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe Dog Vaccines Price by Type (2021-2032)
  5. 9.2 Europe Dog Vaccines Market Size by Application
  6. 9.2.1 Europe Dog Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe Dog Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe Dog Vaccines Price by Application (2021-2032)
  9. 9.3 Europe Dog Vaccines Market Size by Country
  10. 9.3.1 Europe Dog Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Dog Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Dog Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Dog Vaccines Market Size by Type
  2. 10.1.1 China Dog Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China Dog Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China Dog Vaccines Price by Type (2021-2032)
  5. 10.2 China Dog Vaccines Market Size by Application
  6. 10.2.1 China Dog Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China Dog Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China Dog Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Dog Vaccines Market Size by Type
  2. 11.1.1 Asia Dog Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia Dog Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia Dog Vaccines Price by Type (2021-2032)
  5. 11.2 Asia Dog Vaccines Market Size by Application
  6. 11.2.1 Asia Dog Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia Dog Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia Dog Vaccines Price by Application (2021-2032)
  9. 11.3 Asia Dog Vaccines Market Size by Country
  10. 11.3.1 Asia Dog Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Dog Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Dog Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Dog Vaccines Market Size by Type
  2. 12.1.1 SAMEA Dog Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Dog Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Dog Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA Dog Vaccines Market Size by Application
  6. 12.2.1 SAMEA Dog Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Dog Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Dog Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA Dog Vaccines Market Size by Country
  10. 12.3.1 SAMEA Dog Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Dog Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Dog Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Dog Vaccines Value Chain Analysis
  2. 13.1.1 Dog Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Dog Vaccines Production Mode & Process
  6. 13.2 Dog Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Dog Vaccines Distributors
  9. 13.2.3 Dog Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst